Table 4.

Adverse events in FLC patients due to ICI therapy.

Number of patients who discontinued ICIs due to AE	2 (10.1%)
Any grade III or IV AE	4 (21.1%)
Specific AE Data
Elevated LFTs	4 (21.1%)
Fatigue	4 (21.1%)
Hypothyroidism	2 (10.1%)
Nausea	2 (10.1%)
Anaphylaxis	1 (5.3%)
Diarrhea	1 (5.3%)
Hyperthyroidism	1 (5.3%)
Pneumonitis	1 (5.3%)
Pruritis	1 (5.3%)
Pyrexia	1 (5.3%)
Rash	1 (5.3%)
Vomiting	1 (5.3%)
Average Number of AEs experienced by patients	1.1